This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
ISRG Stock Gains on Q2 Earnings & Sales Beat, Gross Margin Contracts
by Zacks Equity Research
Intuitive Surgical's second-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.
BSXPositive Net Change ISRGPositive Net Change CAHPositive Net Change CORPositive Net Change
earnings medical medical-devices
What's Shaping CVS' Health Care Benefits Arm for the Rest of 2025?
by Moumi Mondal
CVS Health's Health Care Benefits arm posts solid Medicare gains and prepares for an ACA exit with a $448M reserve.
UNHNegative Net Change CINegative Net Change CVSPositive Net Change
medical medical-devices
Hims & Hers Paves the Way for Global Digital Health Expansion
by Debanjana Dey
HIMS accelerates its global push with the ZAVA acquisition and a planned Canada launch targeting affordable obesity care.
TDOCNegative Net Change AMWLNegative Net Change HIMSNegative Net Change
medical medical-devices
WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up?
by Zacks Equity Research
West Pharmaceutical targets steady Q2 growth as high-value GLP-1 and SmartDose demand drives segment momentum.
CAHPositive Net Change CORPositive Net Change WSTNo Net Change WGSNegative Net Change
medical medical-devices
Should You Buy AXT (AXTI) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
AXTINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises
by Zacks Equity Research
DGX tops Q2 estimates with 15.2% revenue growth and a strong EPS beat, lifting the stock 3.2% in pre-market trading.
DGXPositive Net Change RMDPositive Net Change CORPositive Net Change VEEVNegative Net Change
earnings medical medical-devices
Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report?
by Moumi Mondal
HOLX heads into Q3 earnings with revenue and EPS estimates down, tariff pressures mounting, and stock lagging peers.
ABTPositive Net Change HOLXPositive Net Change QGENPositive Net Change
earnings-preview medical medical-devices
Buy These 4 Stocks With Solid Net Profit Margin to Maximize Returns
by Anirudha Bhagat
Let's take a look at four stocks, CPRX, GAMB, ORN and BWAY, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.
ORNNegative Net Change CPRXNegative Net Change BWAYNegative Net Change GAMBNegative Net Change
construction medical medical-devices pharmaceuticals
ISRG vs. SYK: Which Robotic Surgery Stock Is the Stronger Buy Today?
by Indrajit Bandyopadhyay
Both are leaders in robotic-assisted surgery - Intuitive Surgical in soft tissue procedures and Stryker in orthopedic surgeries. Which company is a better bet now?
SYKNegative Net Change ISRGPositive Net Change
medical medical-devices
ISRG Stock Before Q2 Earnings Release: To Buy or Not to Buy?
by Zacks Equity Research
Intuitive Surgical's second-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.
MDTNegative Net Change ISRGPositive Net Change TMONegative Net Change
medical medical-devices
Chemung Financial (CHMG)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
CHMGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
ECL Unveils ReadyDose Cleaning Program for Southeast Asian Restaurants
by Zacks Equity Research
Ecolab rolls out ReadyDose, a tablet-based cleaning solution to help Southeast Asian restaurants cut waste and boost hygiene.
ECLNegative Net Change CORPositive Net Change ITGRNegative Net Change HIMSNegative Net Change
medical medical-devices
DGX Q2 Earnings Preview: Will Advanced Diagnostics Lead Performance?
by Zacks Equity Research
Quest Diagnostics' Q2 results may get a lift from Advanced Diagnostics, new health plan deals and recent acquisitions.
DGXPositive Net Change CAHPositive Net Change CORPositive Net Change WGSNegative Net Change
earnings medical medical-devices
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
by Zacks Equity Research
ARAY rides strong global demand and CyberKnife momentum, but order declines and backlog pressure temper the outlook.
BSXPositive Net Change ARAYNegative Net Change CORPositive Net Change PAHCNegative Net Change
medical medical-devices
Should You Buy Datadog (DDOG) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
DDOGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Western Digital (WDC) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
WDCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Enovix Corporation (ENVX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ENVXNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Evercore (EVR) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
EVRNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?
by Moumi Mondal
CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
UNHNegative Net Change HUMNegative Net Change CVSPositive Net Change ELVNegative Net Change
medical medical-devices
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition?
by Indrajit Bandyopadhyay
OptimizeRx bets on EHR-linked messaging and geo-targeting to stand out, but scaling in a crowded digital health field remains key.
OMCLNegative Net Change OPRXNegative Net Change TDOCNegative Net Change
medical medical-devices
Should You Add Edwards Lifesciences Stock to Your Portfolio Now?
by Zacks Equity Research
EW gains traction with surgical tech and TAVR growth, but macro pressures and FX headwinds weigh on margins.
CAHPositive Net Change EWPositive Net Change CORPositive Net Change PAHCNegative Net Change
medical medical-devices
TEM Shares Surge on New AI Breakthrough: Should Investors Jump In?
by Urmimala Biswas
TEM stock rallies 7.3% after the FDA clears its second cardiology AI tool, witnessing a 48% surge in just three months.
AZNPositive Net Change IRTCPositive Net Change SOPHPositive Net Change TEMNegative Net Change
artificial-intelligence healthcare medical medical-devices
ISRG's Vessel Sealer Curved for da Vinci Systems Gets FDA Approval
by Zacks Equity Research
Intuitive Surgical wins FDA nod for its Vessel Sealer Curved, boosting the da Vinci system's precision and multifunctional capabilities.
ISRGPositive Net Change CORPositive Net Change ITGRNegative Net Change HIMSNegative Net Change
medical medical-devices
Hims & Hers Stock Surges 90.4% in 3 Months: What's Fueling the Rally?
by Debanjana Dey
HIMS benefits from strong online revenue, subscriber growth, and global expansion moves to fuel its health platform momentum. However, challenges may hurt performance.
TDOCNegative Net Change AMWLNegative Net Change HIMSNegative Net Change
medical medical-devices
Should You Buy Sensata (ST) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
STNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines